Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions

Marc Tänzer, Benjamin Balluff, Jürgen Distler et al. · 2010

Read Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions by Marc Tänzer, Benjamin Balluff, Jürgen Distler et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009061.txt.

Description

Marc Tänzer and co-authors tested a blood test for early bowel growths, in PLOS ONE in 2010. Screening cuts deaths from colorectal cancer, yet many people skip current tests. Colonoscopy is effective but unpopular; stool tests are often missed. A simple blood draw could win wider acceptance.

The team measured two methylated DNA markers, SEPT9 and ALX4, in blood plasma. They judged how well the pair flagged precancerous lesions, not just cancers. Catching growths before they turn malignant is screening's real prize. Their performance figures show what such a test can and cannot yet do.

Catalog record

CREATORMarc Tänzer, Benjamin Balluff, Jürgen Distler et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009061

Browse the full library · About the Tower of Babel